Estradiol Cream Shortage? What to Ask and What to Do

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published November 2, 2026 · Updated November 2, 2026

If your pharmacy says your estradiol vaginal cream is on backorder, you're not alone. The estradiol cream shortage is part of a wider squeeze on estrogen products: the American Society of Health-System Pharmacists (ASHP) lists estradiol vaginal cream as a current shortage. Here's what that listing and recent reporting say, what to ask your pharmacist and clinician, and why to talk with your clinician before changing or stopping your treatment.

What estradiol vaginal cream is

Estradiol vaginal cream 0.01% is a prescription estrogen cream. One manufacturer's prescribing information (labels can differ by maker, and some may not yet reflect FDA's 2026 boxed-warning updates) says it is used to treat moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, such as dryness and irritation. That label also carries a boxed warning, including about endometrial cancer in people with a uterus who use estrogen alone.

Hormone therapy isn't right for everyone: depending on age, timing, health history and the type used, it can raise the risk of blood clots, stroke and breast cancer, and estrogen without a progestogen raises the risk of uterine cancer in people who have a uterus.

Is there an estradiol cream shortage? What ASHP lists

ASHP's estradiol vaginal cream shortage page, last updated Oct. 26, 2026, covers 0.01% cream in 42.5-gram tubes. According to ASHP:

• Mylan (Viatris), Padagis and Teva "did not provide a reason for the shortage."
• The brand-name maker has its cream available.
• One other maker has estradiol vaginal cream "available to current customers."

ASHP's list tracks what manufacturers report. It isn't a live count of what's on the shelf at your pharmacy, and stock can differ from one store to the next.

Why other forms of estrogen are getting hard to find

Reuters reported on Oct. 28 that women in the U.S. "are facing shortages beyond estrogen patches amid surging demand." In that report:

• A pharmaceutical consultant said the new shortages may partly reflect women switching from patches that have become harder to find to other hormone products. He also said the pattern did not appear to point to a broad lack of raw materials, while cautioning that supply-chain problems could still play a part.
• Viatris said it had seen a "significant surge in demand" and that "we are meeting our current supply plans for estradiol vaginal cream."

None of these sources gives a date for when supply will return to normal, and we can't predict it either.

What to ask your pharmacist

• Is another maker's version in stock?
• Can another store or pharmacy fill my prescription?
• When is your next shipment expected?

Ask before your last tube runs out, so you have time to plan.

What to ask your clinician

• If my cream stays out of stock, is there another FDA-approved, low-dose vaginal form that could fit me? That's a clinician's decision, not a swap to make on your own.
• Can I use a patch or other estrogen I already have instead? Ask how a vaginal cream and a hormone patch differ; they are different products, and only your clinician can decide whether any change makes sense for you.
• What should I watch for? The cream's prescribing information says it should not be used by people with undiagnosed abnormal genital bleeding, so tell your clinician about any vaginal bleeding after menopause.

Talk to your clinician before changing or stopping

It can be tempting to use less cream to make a tube last, or to stop when a refill is delayed. Talk with your clinician before changing how you use it or stopping. They can help you plan for a gap and decide on any change.

Prescriptions, when appropriate, are issued by licensed clinicians.

To learn more about who we are, see about Kindr Health.

If your treatment plan has hit a supply snag, Kindr's board-certified clinicians can talk through your options. Start at kindr.health. Treatment options vary by state and clinical eligibility.

Sources: ASHP, "Drug Shortage Detail: Estradiol Vaginal Cream" (updated Oct 26, 2026); Reuters via Investing.com, "US estrogen supply crunch widens as women seek alternatives to scarce patches" (Oct 28, 2026); DailyMed, Estradiol Vaginal Cream, USP, 0.01% (one manufacturer's label, May 2025); FDA, "Menopausal Hormone Therapies: Updated Prescribing Information".

This article is for educational purposes only and is not medical advice. It does not replace a consultation with a licensed healthcare professional. Talk with your clinician before starting, stopping or changing any treatment. See our full medical disclaimer.

Medically reviewed by Kindr Health Clinical Team
Last updated: November 2, 2026